<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36834005</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Measurement Properties of Self-Report Questionnaires for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis of Commonly Used Instruments.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20043310</ELocationID><Abstract><AbstractText>(1) Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. There is no evidence on the analysis of the measurement instruments available to assess quality of life in these patients, following the consensus-based standards for the selection of health measurement instruments (COSMIN) checklist; (2) Methods: A systematic review was performed in PubMed, Embase, PEDro, Web of Science and Cochrane. The psychometric properties of the questionnaires were determined by using the COSMIN checklist. Two searches were carried out. This systematic review was registered in PROSPERO (CRD42021249005); (3) Results: There were four published articles that analysed the measurement properties in patients with ALS for the following scales: Amyotrophic Lateral Sclerosis Assessment Questionnaire 40, Amyotrophic Lateral Sclerosis-Specific Quality of Life Questionnaire, Short Form 36 Healthy Survey, Epworth Sleepiness Scale and Sickness Impact Profile. Another five scales also met the inclusion criteria: ALS-Depression-Inventory, State Trait Anxiety-Inventory, World Health Organization Quality of Life, Schedule for the Evaluation of Individual Quality of Life, Amyotrophic Lateral Sclerosis Assessment Questionnaire 5. Most Patient Reported Outcome Measures (PROMs) present a low-quality synthesis of evidence. It was observed an excellent pooled reliability of 0.92 (95% Confidence Interval: 0.83-0.96, I<sup>2</sup> = 87.3%) for four dimensions for questionnaires ALSAQ-40. (4) Conclusions: There is little evidence on generic instruments. Future studies are necessary to develop new tools.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanchez-Andrades</LastName><ForeName>Maria Jose</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Health Science, Ampliacion de Campus de Teatinos, University of Malaga, C/Arquitecto Francisco Pe&#xf1;alosa 3, 29071 Malaga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinolo-Gil</LastName><ForeName>Maria Jesus</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-4589-4442</Identifier><AffiliationInfo><Affiliation>Department of Nursing and Physiotherapy, Faculty of Nursing and Physiotherapy, University of Cadiz, 11009 Cadiz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CMU Rehabilitation Intercentres-Interlevels Puerto Real and Cadiz Hospitals, C&#xe1;diz-La Janda Health District, 11006 Cadiz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casuso-Holgado</LastName><ForeName>Mar&#xed;a Jes&#xfa;s</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-4217-6827</Identifier><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, 41009 Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bar&#xf3;n-L&#xf3;pez</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8707-304X</Identifier><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Health Science, Ampliacion de Campus de Teatinos, University of Malaga, C/Arquitecto Francisco Pe&#xf1;alosa 3, 29071 Malaga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Huguet</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0921-8263</Identifier><AffiliationInfo><Affiliation>Department of Nursing and Physiotherapy, Faculty of Nursing and Physiotherapy, University of Cadiz, 11009 Cadiz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Valero</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1664-3647</Identifier><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Health Science, Ampliacion de Campus de Teatinos, University of Malaga, C/Arquitecto Francisco Pe&#xf1;alosa 3, 29071 Malaga, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">design questionnaire</Keyword><Keyword MajorTopicYN="N">patient reported outcome measures</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">validation studies</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36834005</ArticleId><ArticleId IdType="pmc">PMC9959245</ArticleId><ArticleId IdType="doi">10.3390/ijerph20043310</ArticleId><ArticleId IdType="pii">ijerph20043310</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martinez-Campo Y., Homedes C., Lazaro A., Alarcon R., Campo D., Riera M., Dominguez R., Povedano M.M., Casasnovas C., Mart&#xed;nez-Campo Y., et al. Observational Study of Patients in Spain with Amyotrophic Lateral Sclerosis: Correlations between Clinical Status, Quality of Life, and Dignity. BMC Palliat. Care. 2017;16:1&#x2013;7. doi: 10.1186/s12904-017-0260-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12904-017-0260-6</ArticleId><ArticleId IdType="pmc">PMC5735656</ArticleId><ArticleId IdType="pubmed">29258495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Leigh P.N. Amyotrophic Lateral Sclerosis. Orphanet J. Rare Dis. 2009;4:1&#x2013;22. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshiri H., Fatehi F., Abolfazli R., Harirchian M.H., Sedighi B., Zamani B., Roudbari A., Razazian N., Khamseh F., Nafissi S. Trends of Quality of Life Changes in Amyotrophic Lateral Sclerosis Patients. J. Neurol. Sci. 2016;368:35&#x2013;40. doi: 10.1016/j.jns.2016.06.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.056</ArticleId><ArticleId IdType="pubmed">27538598</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic Lateral Sclerosis: A Clinical Review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Hombrados L., Molina-Torres G., Gal&#xe1;n-Mercant A., S&#xe1;nchez-Guerrero E., Gonz&#xe1;lez-S&#xe1;nchez M., Ruiz-Mu&#xf1;oz M. Systematic Review of Therapeutic Physical Exercise in Patients with Amyotrophic Lateral Sclerosis over Time. Int. J. Environ. Res. Public Health. 2021;18:1074. doi: 10.3390/ijerph18031074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18031074</ArticleId><ArticleId IdType="pmc">PMC7908444</ArticleId><ArticleId IdType="pubmed">33530383</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip P.A., Carlton J., Woods H.B., Mazzone P. Measuring Quality of Life in Duchenne Muscular Dystrophy: A Systematic Review of the Content and Structural Validity of Commonly Used Instruments. Health Qual. Life Outcomes. 2020;18:263. doi: 10.1186/s12955-020-01511-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01511-z</ArticleId><ArticleId IdType="pmc">PMC7397669</ArticleId><ArticleId IdType="pubmed">32746836</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G., Grp P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (Reprinted from Annals of Internal Medicine) Phys. Ther. 2009;89:873&#x2013;880. doi: 10.1093/ptj/89.9.873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/89.9.873</ArticleId><ArticleId IdType="pubmed">19723669</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackintosh A., Casa&#xf1;as i Comabella C., Hadi M., Gibbons E., Fitzpatrick R., Roberts N. Prom Group Construct &amp; Instrument Type Filters. Volume 44 University of Oxford; Oxford, UK: 2010.</Citation></Reference><Reference><Citation>Terwee C.B., Prinsen C.A.C., Ricci Garotti M.G., Suman A., de Vet H.C.W., Mokkink L.B. The Quality of Systematic Reviews of Health-Related Outcome Measurement Instruments. Qual. Life Res. 2016;25:767&#x2013;779. doi: 10.1007/s11136-015-1122-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-015-1122-4</ArticleId><ArticleId IdType="pmc">PMC4830864</ArticleId><ArticleId IdType="pubmed">26346986</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke S., Hickey A., O&#x2019;Boyle C., Hardiman O. Assessing Individual Quality of Life in Amyotrophic Lateral Sclerosis. Qual. Life Res. 2001;10:149&#x2013;158. doi: 10.1023/A:1016704906100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1016704906100</ArticleId><ArticleId IdType="pubmed">11642685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokkink L.B., de Vet H.C.W., Prinsen C.A.C., Patrick D.L., Alonso J., Bouter L.M., Terwee C.B. COSMIN Risk of Bias Checklist for Systematic Reviews of Patient-Reported Outcome Measures. Qual. Life Res. 2018;27:1171&#x2013;1179. doi: 10.1007/s11136-017-1765-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-017-1765-4</ArticleId><ArticleId IdType="pmc">PMC5891552</ArticleId><ArticleId IdType="pubmed">29260445</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwee C.B., Prinsen C.A.C., Chiarotto A., Westerman M.J., Patrick D.L., Alonso J., Bouter L.M., de Vet H.C.W., Mokkink L.B. COSMIN Methodology for Evaluating the Content Validity of Patient-Reported Outcome Measures: A Delphi Study. Qual. Life Res. 2018;27:1159&#x2013;1170. doi: 10.1007/s11136-018-1829-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-018-1829-0</ArticleId><ArticleId IdType="pmc">PMC5891557</ArticleId><ArticleId IdType="pubmed">29550964</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokkink L.B., Prinsen C.A., Patrick D.L., Alonso J., Bouter L.M., de Vet H.C., Terwee C.B. COSMIN Manual for Systematic Reviews of PROMs, User Manual.  [(accessed on 10 November 2022)];Qual Life Res. 2018 :1&#x2013;78. Available online:  https://www.cosmin.nl/tools/guideline-conducting-systematic-review-outcome-measures/</Citation></Reference><Reference><Citation>Terwee C.B., Mokkink L.B., Knol D.L., Ostelo R.W.J.G., Bouter L.M., De Vet H.C.W. Rating the Methodological Quality in Systematic Reviews of Studies on Measurement Properties: A Scoring System for the COSMIN Checklist. Qual. Life Res. 2012;21:651&#x2013;657. doi: 10.1007/s11136-011-9960-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9960-1</ArticleId><ArticleId IdType="pmc">PMC3323819</ArticleId><ArticleId IdType="pubmed">21732199</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Thompson S.G. Quantifying Heterogeneity in a Meta-Analysis. Stat. Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakstian A.R., Whalen T.E. A K-Sample Significance Test for Independent Alpha Coefficients. Psychometrika. 1976;41:219&#x2013;231. doi: 10.1007/BF02291840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02291840</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Meca J., L&#xf3;pez-L&#xf3;pez J.A., L&#xf3;pez-Pina J.A. Some Recommended Statistical Analytic Practices When Reliability Generalization Studies Are Conducted. Br. J. Math. Stat. Psychol. 2013;66:402&#x2013;425. doi: 10.1111/j.2044-8317.2012.02057.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8317.2012.02057.x</ArticleId><ArticleId IdType="pubmed">23046285</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant J., Hunter A. Measuring Inconsistency in Knowledgebases. J. Intell. Inf. Syst. 2006;27:159&#x2013;184. doi: 10.1007/s10844-006-2974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10844-006-2974-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks J.J., Higgins J.P.T., Altman D.G. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Wiley; Hoboken, NJ, USA: 2019. Analysing Data and Undertaking Meta-Analyses; pp. 241&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9781119536604.ch10</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonett D.G. Varying Coefficient Meta-Analytic Methods for Alpha Reliability. Psychol. Methods. 2010;15:368&#x2013;385. doi: 10.1037/a0020142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0020142</ArticleId><ArticleId IdType="pubmed">20853952</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xdc;bler A., Winter S., Kaiser J., Birmbaumer N., Hautziner M. The ALS Depression Inventory (ADI): A Questionnaire to Assess Depression in Patients with Neurodegenerative Dieases. Z. Klin. Psychol. Psychother. 2005;34:19&#x2013;26. doi: 10.1026/1616-3443.34.1.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1026/1616-3443.34.1.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielberg C. Manual for the State-Trait Anxiety Inventory (STAI Form Y) Consulting Psychologists Press; Sunnyvale, CA, USA: 1983.</Citation></Reference><Reference><Citation>Brazier J.E., Harper R., Jones N.M.B., O&#x2019;Cathain A., Thomas K.J., Usherwood T., Westlake L. Validating the SF-36 Health Survey Questionnaire: New Outcome Measure for Primary Care. Br. Med. J. 1992;305:160&#x2013;164. doi: 10.1136/bmj.305.6846.160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.305.6846.160</ArticleId><ArticleId IdType="pmc">PMC1883187</ArticleId><ArticleId IdType="pubmed">1285753</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons Z., Felgoise S.H., Bremer B.A., Walsh S.M., Hufford D.J., Bromberg M.B., David W., Forshew D.A., Heiman-Patterson T.D., Lai E.C., et al. The ALSSQOL-Balancing Physical and Nonphysical Factors in Assessing Quality of Life in ALS. Neurology. 2006;67:1659&#x2013;1664. doi: 10.1212/01.wnl.0000242887.79115.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000242887.79115.19</ArticleId><ArticleId IdType="pubmed">17101900</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C. Development and Validation of a Short Measure of Health Status for Individuals with Amyotrophic Lateral Sclerosis/Motor Neurone Disease: The ALSAQ-40. J. Neurol. Suppl. 1999;246:16&#x2013;21. doi: 10.1007/BF03161085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03161085</ArticleId><ArticleId IdType="pubmed">10631656</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C., Fitzpatrick R. Reduced Item Set for the Amyotrophic Lateral Sclerosis Assessment Questionnaire: Development and Validation of the ALSAQ-5. J. Neurol. Neurosurg. Psychiatry. 2001;70:70&#x2013;73. doi: 10.1136/jnnp.70.1.70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.70.1.70</ArticleId><ArticleId IdType="pmc">PMC1763474</ArticleId><ArticleId IdType="pubmed">11118250</ArticleId></ArticleIdList></Reference><Reference><Citation>Group T.E. EuroQol-a New Facility for the Measurement of Health-Related Quality of Life. Health Policy. 1990;16:199&#x2013;208. doi: 10.1016/0168-8510(90)90421-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8510(90)90421-9</ArticleId><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin Cohen S., Mount B.M., Strobel M.G., Bui F. The McGill Quality of Life Questionnaire: A Measure of Quality of Life Appropriate for People with Advanced Disease. A Preliminary Study of Validity and Acceptability. Palliat. Med. 1995;9:207&#x2013;219. doi: 10.1177/026921639500900306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/026921639500900306</ArticleId><ArticleId IdType="pubmed">7582177</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays R.D., Bjorner J.B., Revicki D.A., Spritzer K.L., Cella D. Development of Physical and Mental Health Summary Scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Items. Qual. Life Res. 2009;18:873&#x2013;880. doi: 10.1007/s11136-009-9496-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-009-9496-9</ArticleId><ArticleId IdType="pmc">PMC2724630</ArticleId><ArticleId IdType="pubmed">19543809</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Boyle C.A. The Schedule for the Evaluation of Individual Quality of Life (SEIQoL) Int. J. Ment. Health. 1994;23:3&#x2013;23. doi: 10.1080/00207411.1994.11449285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207411.1994.11449285</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanda U., McLendon P.M., Andresen E.M., Armbrecht E. The SIP68: An Abbreviated Sickness Impact Profile for Disability Outcomes Research. Qual. Life Res. 2003;12:583&#x2013;595. doi: 10.1023/A:1025036325886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1025036325886</ArticleId><ArticleId IdType="pubmed">13677503</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO QOL WHO Quality of Life Scale (WHOQOL) Psychol. Med. 1998;28:551&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pubmed">9626712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammer E.M., Haecker S., Hautzinger M., Meyer T.D., Kuebler A. Validity of the ALS-Depression-Inventory (ADI-12)-A New Screening Instrument for Depressive Disorders in Patients with Amyotrophic Lateral Sclerosis. J. Affect. Disord. 2008;109:213&#x2013;219. doi: 10.1016/j.jad.2007.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2007.11.012</ArticleId><ArticleId IdType="pubmed">18262283</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. Beck Inventory for Measuring Depression. Arch. Gen. Psychiatry. 1961;4:561&#x2013;571. doi: 10.1001/archpsyc.1961.01710120031004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1961.01710120031004</ArticleId><ArticleId IdType="pubmed">13688369</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. A Rating Scale for Depression. J. Neurol. Neurosurg. Psychiat. 1960;23:56&#x2013;63. doi: 10.1136/jnnp.23.1.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.23.1.56</ArticleId><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt S.M., McEwen J. The Development of a Subjective Health Indicator. Sociol. Health Illn. 1980;2:231&#x2013;246. doi: 10.1111/1467-9566.ep11340686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1467-9566.ep11340686</ArticleId><ArticleId IdType="pubmed">10298135</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns M.W. A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep. 1991;14:540&#x2013;545. doi: 10.1093/sleep/14.6.540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/14.6.540</ArticleId><ArticleId IdType="pubmed">1798888</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp L.B., Larocca N.G., Muir Nash J., Steinberg A.D. The Fatigue Severity Scale: Application to Patients with Multiple Sclerosis and Systemic Lupus Erythematosus. Arch. Neurol. 1989;46:1121&#x2013;1123. doi: 10.1001/archneur.1989.00520460115022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercoulen J.H.M.M., Swanink C.M.A., Fennis J.F.M., Galama J.M.D., van der Meer J.W.M., Bleijenberg G. Dimensional Assessment of Chronic Fatigue Syndrome. J. Psychosom. Res. 1994;38:383&#x2013;392. doi: 10.1016/0022-3999(94)90099-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(94)90099-X</ArticleId><ArticleId IdType="pubmed">7965927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond A.S., Snalth R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. [Revista En Internet] 2014 [Acceso 28 de Noviembre de 2019. Acta Psychiatr. Scand. 1983;67:361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C., Fitzpatrick R., Brennan C., Swash M. Evidence for the Validity and Reliability of the ALS Assessment Questionnaire: The ALSAQ-40. Amyotroph. Lateral Scler. 2000;1:33&#x2013;40. doi: 10.1080/146608299300080022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608299300080022</ArticleId><ArticleId IdType="pubmed">12365067</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C., Levvy G., Fitzpatrick R., Garratt A. The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40): Tests of Data Quality, Score Reliability and Response Rate in a Survey of Patients. J. Neurol. Sci. 2000;180:94&#x2013;100. doi: 10.1016/S0022-510X(00)00420-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00420-2</ArticleId><ArticleId IdType="pubmed">11090872</ArticleId></ArticleIdList></Reference><Reference><Citation>Norquist J.M., Fitzpatrick R., Jenkinson C. Health-Related Quality of Life in Amyotrophic Lateral Sclerosis: Determining a Meaningful Deterioration. Qual. Life Res. 2004;13:1409&#x2013;1414. doi: 10.1023/B:QURE.0000040786.75103.3a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:QURE.0000040786.75103.3a</ArticleId><ArticleId IdType="pubmed">15503836</ArticleId></ArticleIdList></Reference><Reference><Citation>Maessen M., Post M.W., Maille R., Lindeman E., Mooij R., Veldink J.H., Van Den Berg L.H., Maill&#xe9; R., Lindeman E., Mooij R., et al. Validity of the Dutch Version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5. Amyotroph. Lateral Scler. 2007;8:96&#x2013;100. doi: 10.1080/17482960601012541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960601012541</ArticleId><ArticleId IdType="pubmed">17453637</ArticleId></ArticleIdList></Reference><Reference><Citation>Salas T., Mora J.J., Esteban J.J., Rodriguez F., Diaz-Lobato S., Fajardo M.M., Rodr&#xed;guez F., D&#xed;az-Lobato S., Fajardo M.M. Spanish Adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS Patients. Amyotroph. Lateral Scler. 2008;9:168&#x2013;172. doi: 10.1080/17482960801934072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801934072</ArticleId><ArticleId IdType="pubmed">18574761</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri A., Sorar&#xfa; G., Lombardi L., D&#x2019;Ascenzo C., Baggio L., Ermani M., Pegoraro E., Angelini C., Soraru G., Lombardi L., et al. Quality of Life and Motor Impairment in ALS: Italian Validation of ALSAQ. Neurol. Res. 2010;32:32&#x2013;40. doi: 10.1179/174313209X385734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/174313209X385734</ArticleId><ArticleId IdType="pubmed">20092693</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshiri H., Eshraghian M.R., Ameli N., Nafissi S. Validation of the Persian Version of the 40-Item Amyotrophic Lateral Sclerosis Assessment Questionnaire. Iran. J. Neurol. 2013;12:102&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3829291</ArticleId><ArticleId IdType="pubmed">24250914</ArticleId></ArticleIdList></Reference><Reference><Citation>Alankaya N., Tulek Z., Ozakgul A., Kaya A., Dik A. Validity and Reliability of the Turkish Version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire. J. Neurosci. Nurs. 2019;51:253&#x2013;258. doi: 10.1097/JNN.0000000000000466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JNN.0000000000000466</ArticleId><ArticleId IdType="pubmed">31469706</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J., Hong G.R.S., Kim S.H., Kim J.A. Translation and Psychometric Evaluation of a Korean Version of the Amyotrophic Lateral Sclerosis-Specific Quality of Life&#x2013;Revised. Amyotroph. Lateral Scler. Front. Degener. 2017;18:92&#x2013;98. doi: 10.1080/21678421.2016.1249885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1249885</ArticleId><ArticleId IdType="pubmed">27922756</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke S.C., McColl E., Shaw P.J., Gibson G.J. Validation of Quality of Life Instruments in ALS. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2004;5:55&#x2013;60. doi: 10.1080/14660820310016066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310016066</ArticleId><ArticleId IdType="pubmed">15204025</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields R.K., Ruhland J.L., Ross M.A., Saehler M.M., Smith K.B., Heffner M.L. Analysis of Health-Related Quality of Life and Muscle Impairment in Individuals with Amyotrophic Lateral Sclerosis Using the Medical Outcome Survey and the Tufts Quantitative Neuromuscular Exam. Arch. Phys. Med. Rehabil. 1998;79:855&#x2013;862. doi: 10.1016/S0003-9993(98)90370-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-9993(98)90370-7</ArticleId><ArticleId IdType="pubmed">9685105</ArticleId></ArticleIdList></Reference><Reference><Citation>Neudert C., Wasner M., Borasio G.D. Patients&#x2019; Assessment of Quality of Life Instruments: A Randomised Study of SIP, SF-36 and SEIQoL-DW in Patients with Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2001;191:103&#x2013;109. doi: 10.1016/S0022-510X(01)00612-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00612-8</ArticleId><ArticleId IdType="pubmed">11676999</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C., Hobart J., Chandola T., Fitzpatrick R., Peto V., Swash M. Use of the Short Form Health Survey (SF-36) in Patients with Amyotrophic Lateral Sclerosis: Tests of Data Quality, Score Reliability, Response Rate and Scaling Assumptions. J. Neurol. 2002;249:178&#x2013;183. doi: 10.1007/PL00007861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00007861</ArticleId><ArticleId IdType="pubmed">11985383</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallmeijer A.J., Dekker J., Knol D.L., Kalmijn S., Schepers V.P.M., de Groot V., Lindeman E., Beelen A., Lankhorst G.J. Dimensional Structure of the SF-36 in Neurological Patients. J. Clin. Epidemiol. 2006;59:541&#x2013;543. doi: 10.1016/j.jclinepi.2005.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2005.11.001</ArticleId><ArticleId IdType="pubmed">16632144</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallmeijer A.J., de Groot V., Roorda L.D., Schepers V.P.M., Lindeman E., van den Berg L.H., Beelen A., Dekker J., Lankhorst G.J., IJzerman M.J., et al. Cross-Diagnostic Validity of the SF-36 Physical Functioning Scale in Patients with Stroke, Multiple Sclerosis and Amyotrophic Lateral Sclerosis: A Study Using Rasch Analysis. J. Rehabil. Med. 2007;39:163&#x2013;169. doi: 10.2340/16501977-0024.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-0024</ArticleId><ArticleId IdType="pubmed">17351700</ArticleId></ArticleIdList></Reference><Reference><Citation>Young C.A., Mills R., Al-Chalabi A., Burke G., Chandran S., Dick D.J., Ealing J., Hanemann C.O., Harrower T., Mcdermott C.J., et al. Measuring Quality of Life in ALS/MND: Validation of the WHOQOL-BREF. Amyotroph. Lateral Scler. Front. Degener. 2020;21:364&#x2013;372. doi: 10.1080/21678421.2020.1752244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1752244</ArticleId><ArticleId IdType="pubmed">32597226</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M., Trojano L., Trojsi F., Monsurro M.R., Tedeschi G., Santangelo G. Assessing Anxiety and Its Correlates in Amyotrophic Lateral Sclerosis: The State-Trait Anxiety Inventory. Muscle Nerve. 2019;60:47&#x2013;55. doi: 10.1002/mus.26475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26475</ArticleId><ArticleId IdType="pubmed">30897219</ArticleId></ArticleIdList></Reference><Reference><Citation>Felgoise S.H., Stewart J.L., Bremer B.A., Walsh S.M., Bromberg M.B., Simmons Z. The SEIQoL-DW for Assessing Quality of Life in ALS: Strengths and Limitations. Amyotroph. Lateral Scler. 2009;10:456&#x2013;462. doi: 10.3109/17482960802444840.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802444840</ArticleId><ArticleId IdType="pubmed">19922140</ArticleId></ArticleIdList></Reference><Reference><Citation>Veroniki A.A., Jackson D., Viechtbauer W., Bender R., Bowden J., Knapp G., Kuss O., Higgins J.P., Langan D., Salanti G. Methods to Estimate the Between-Study Variance and Its Uncertainty in Meta-Analysis. Res. Synth. Methods. 2016;7:55&#x2013;79. doi: 10.1002/jrsm.1164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1164</ArticleId><ArticleId IdType="pmc">PMC4950030</ArticleId><ArticleId IdType="pubmed">26332144</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavan K., Marangoni B.E.M., Zinezzi M.O., Schmidt K.B., Oliveira B.C., Buainain R.P., Lianza S. Validation of the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) Scale in the Portuguese Language. Arq. Neuropsiquiatr. 2010;68:48&#x2013;51. doi: 10.1590/S0004-282X2010000100011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X2010000100011</ArticleId><ArticleId IdType="pubmed">20339652</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>